Marc TESSIER-LAVIGNE was elected tenth president of The Rockefeller University by its Board of Trustees on September 8, 2010 following an international search. He began on March 16, 2011.
A world leader in the study of brain development, Marc has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. The mechanisms he has identified are important for understanding how the human brain forms during normal development, and are increasingly being implicated in a variety of other processes, including vascular patterning and axonal regeneration following spinal cord injury, as well as neurodegeneration such as that seen in Alzheimerís disease.
A native of Trenton, Canada, Marc obtained his Ph.D. from University College London and performed postdoctoral work at the MRC Developmental Neurobiology Unit in London and at Columbia University. He has been on the faculty of the University of California, San Francisco and Stanford University and has been a Howard Hughes Medical Institute investigator. In 2003, Marc joined Genentech, one of the world's leading biotech companies, where he oversaw 1,400 people in disease research and drug discovery as executive vice president and chief scientific officer.
He is the recipient of numerous scientific awards and is an elected member of the U.S. National Academy of Sciences and a fellow of the Royal Societies of the U.K. and Canada.